
A new study has suggested that dementia patients may not require as high a dosage of antipsychotic medication that was …

Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …
The loss of exclusivity on Eli Lilly’s blockbuster antipsychotic Zyprexa hit the company hard in 2012, with the firm’s overall …
AstraZeneca has added a new heart warning to the packaging on its antipsychotic drug Seroquel at the behest of the …
Janssen’s injectable antipsychotic Xeplion has been approved by the European Commission for the treatment of schizophrenia. There is no cure …

